Immediate Impact
25 standout
Citing Papers
Oesophageal cancer
2024 Standout
Advances in diagnosis and management of cancer of the esophagus
2024 Standout
Works of Suresh Varma being referenced
Panitumumab added to docetaxel, cisplatin and fluoropyrimidine in oesophagogastric cancer: ATTAX3 phase II trial
2016
Final results of AGITG ATTAX3 study: Randomized phase II study of weekly docetaxel (T), cisplatin, and fluoropyrimidine (F) with or without panitumumab (P) in advanced esophagogastric (OG) cancer.
2013
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Suresh Varma | 96 | 111 | 19 | 58 | 9 | 213 | |
| Trish Green | 55 | 123 | 22 | 87 | 17 | 269 | |
| Leslie Byatt | 87 | 116 | 16 | 36 | 5 | 216 | |
| Helen Roe | 65 | 96 | 34 | 47 | 8 | 233 | |
| Mehak Nanda | 104 | 89 | 10 | 88 | 9 | 296 | |
| A. Alexanian | 29 | 75 | 29 | 64 | 9 | 218 | |
| Mahlet Kifle Habtemariam | 71 | 111 | 23 | 37 | 15 | 298 | |
| Rachel English | 103 | 81 | 57 | 88 | 11 | 290 | |
| Michele J. Josey | 69 | 70 | 21 | 29 | 12 | 221 | |
| Salman Ahmed | 85 | 36 | 22 | 45 | 18 | 279 | |
| Frank C. Day | 98 | 42 | 8 | 99 | 14 | 292 |
All Works
Loading papers...